Sex determines cardiac and renal Vulnerability to chronic hemoglobin toxicity

Daniela Lucas1, Carlos Munoz1, Andre F Palmer2

  • 1Shu Chien-Gene Lay Department of Bioengineering - University of California, San Diego, CA, United States.

Hemolytic anemias are characterized by chronic intravascular hemolysis, leading to sustained release of acellular hemoglobin (Hb). Circulating Hb scavenges nitric oxide, releases redox-active heme, and promotes oxidative and inflammatory injury, contributing to progressive cardiac and renal dysfunction. Despite the known cardiopulmonary and renal complications in hemolytic disorders, the direct mechanisms of Hb-mediated injury and the influence of sex as a biological variable remain partially understood. In this study, we investigated the effects of chronic Hb exposure on cardiac and renal function in male and female mice. Animals received daily intraperitoneal injections of acellular Hb (320 mg/kg) for six weeks. Cardiac function was evaluated by echocardiography, renal function by transdermal glomerular filtration rate, and tissue injury biomarkers were quantified by ELISA. Mitochondrial respiratory function was also assessed in cardiac and renal tissues. Chronic Hb exposure induced significant cardiac dysfunction and renal impairment in male mice, evidenced by reduced ejection fraction, decreased stroke volume, diminished glomerular filtration rate, and elevated injury biomarkers. In contrast, female mice showed less impairment of cardiac and renal function and exhibited lower levels of biomarkers. Mitochondrial respiration revealed marked reductions in bioenergetics in males, whereas females maintained superior mitochondrial bioenergetics in both organs. These findings identify mitochondrial dysfunction as a mechanistic link between chronic Hb exposure and multi-organ injury and demonstrate sex-dependent bioenergetic adaptability as a key determinant of disease severity. Collectively, this work underscores the importance of incorporating sex as a biological variable and supports the development of Hb-neutralizing therapeutic strategies to mitigate Hb-induced organ damage.

Related Concept Videos

Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
157
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
8.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
804